[Fetal sex determination with real time PCR of fetal DNA in maternal plasma]
- PMID: 14725206
[Fetal sex determination with real time PCR of fetal DNA in maternal plasma]
Abstract
Introduction: Non-invasive methods using maternal plasma and serum for molecular genetic diagnosis become an important field of interest in prenatal genetic diagnosis. Free fetal DNA in maternal plasma and serum has been shown to be useful for fetal gender determination, and seems to offer a new possibility to perform non-invasive prenatal genetic diagnosis. A possible application is fetal sex determination for couples at risk of X-linked diseases. The aim of this study was to control the reliability and reproducibility of the real-time PCR amplification of the SRY region.
Materials and methods: Maternal serum before amniocentesis, and amnionic fluid samples were obtained from 56 pregnant women during the 11th to 22nd weeks of gestation. Real-time PCR analysis of the SRY region was performed in order to determine the fetal sex. Routine karyotyping of cultured amnionic cells was also performed on the samples. Six cases were excluded.
Results: In 26 of 50 pregnancies were found male fetuses by cytogenetic analysis. Real time PCR of maternal plasma has been positive for the SRY region in 27 cases. In 47 cases the cytogenetic gender and the real-time PCR result was correlating. In one case of 46,XY karyotype the PCR reaction for SRY region was negative, in two cases of SRY positivity the karyotype was 46,XX. In this study are presented the results of fetal sex determination in maternal plasma using real time PCR method.
Conclusions: The real time PCR detection of fetal DNA in maternal plasma seems to be an easy non-invasive method to determine the fetal sex at this gestational age. Our experience is promising in terms of the specificity and sensitivity of the method.
Similar articles
-
Non-invasive fetal sex determination using real-time PCR.J Matern Fetal Neonatal Med. 2006 Jun;19(6):337-42. doi: 10.1080/14767050600593320. J Matern Fetal Neonatal Med. 2006. PMID: 16801309
-
Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination.Prenat Diagn. 2003 Mar;23(3):235-8. doi: 10.1002/pd.556. Prenat Diagn. 2003. PMID: 12627426
-
Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.Acta Obstet Gynecol Scand. 2007;86(5):535-41. doi: 10.1080/00016340601159124. Acta Obstet Gynecol Scand. 2007. PMID: 17464580
-
[Fetal DNA in maternal blood].Ned Tijdschr Geneeskd. 2004 Jan 24;148(4):170-4. Ned Tijdschr Geneeskd. 2004. PMID: 14974307 Review. Dutch.
-
[Genetic analysis of the fetus using maternal blood].Gynecol Obstet Fertil. 2004 Jul-Aug;32(7-8):646-50. doi: 10.1016/j.gyobfe.2004.04.011. Gynecol Obstet Fertil. 2004. PMID: 15450264 Review. French.
Cited by
-
Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis.BMC Res Notes. 2012 Sep 1;5:476. doi: 10.1186/1756-0500-5-476. BMC Res Notes. 2012. PMID: 22937795 Free PMC article. Review.
-
Evaluation of an Improved Non-invasive Fetal Sex Determination in Haemophilia A Patients.J Clin Diagn Res. 2015 Jul;9(7):GC01-4. doi: 10.7860/JCDR/2015/12556.6175. Epub 2015 Jul 1. J Clin Diagn Res. 2015. PMID: 26393142 Free PMC article.